For: | Chrysavgis L, Ztriva E, Protopapas A, Tziomalos K, Cholongitas E. Nonalcoholic fatty liver disease in lean subjects: Prognosis, outcomes and management. World J Gastroenterol 2020; 26(42): 6514-6528 [PMID: 33268944 DOI: 10.3748/wjg.v26.i42.6514] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v26/i42/6514.htm |
Number | Citing Articles |
1 |
Ioannis I. Moustakas, Angeliki Katsarou, Aigli-Ioanna Legaki, Iryna Pyrina, Konstantinos Ntostoglou, Alkistis-Maria Papatheodoridi, Bettina Gercken, Ioannis S. Pateras, Vassilis G. Gorgoulis, Michael Koutsilieris, Triantafyllos Chavakis, Antonios Chatzigeorgiou. Hepatic Senescence Accompanies the Development of NAFLD in Non-Aged Mice Independently of Obesity. International Journal of Molecular Sciences 2021; 22(7): 3446 doi: 10.3390/ijms22073446
|
2 |
Tuo Han, Ying Li, Jing Xiao, Hong Gong, Fuxue Deng, Wei Jiang, Congxia Wang, Fangyao Chen, Chunyan Zhang, Jie Deng, Yan Zhang. Diagnostic Utility of Triglyceride-Glucose Index in Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study on Lean Population. Diabetes, Metabolic Syndrome and Obesity 2024; : 3547 doi: 10.2147/DMSO.S469398
|
3 |
Óscar Osorio-Conles, Arturo Vega-Beyhart, Ainitze Ibarzabal, José María Balibrea, Isabel Graupera, Jordi Rimola, Josep Vidal, Ana de Hollanda. A Distinctive NAFLD Signature in Adipose Tissue from Women with Severe Obesity. International Journal of Molecular Sciences 2021; 22(19): 10541 doi: 10.3390/ijms221910541
|
4 |
Nilay Danis, Sharon R. Weeks, Ahyoung Kim, Azarakhsh Baghdadi, Maryam Ghadimi, Ihab R. Kamel, Behnam Saberi, Tinsay Woreta, Jacqueline Garonzik‐Wang, Benjamin Philosophe, Ahmet Gurakar, Rohit Loomba. Noninvasive Risk Stratification for Nonalcoholic Fatty Liver Disease Among Living Liver Donor Candidates: A Proposed Algorithm. Liver Transplantation 2022; 28(4): 670 doi: 10.1002/lt.26365
|
5 |
Nursel Çalık Başaran, İlkay İdilman, Hayriye Altunay Tokuçoğlu, Mehmet Ruhi Onur, Meliha Çağla Sönmezer, Lale Özışık, Muşturay Karçaaltıncaba, Ahmet Çağkan İnkaya, Serhat Ünal. Detection of Non-Alcoholic Fatty Liver Disease with Non-invasive Tools
in Turkish People Living with HIV and with Apparently Normal Liver
Function. Current HIV Research 2023; 21(3): 192 doi: 10.2174/1570162X21666230714122716
|
6 |
Jarren R. Oates, Keisuke Sawada, Daniel A. Giles, Pablo C. Alarcon, Michelle S.M.A. Damen, Sara Szabo, Traci E. Stankiewicz, Maria E. Moreno-Fernandez, Senad Divanovic. Thermoneutral housing shapes hepatic inflammation and damage in mouse models of non-alcoholic fatty liver disease. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1095132
|
7 |
Francesco Baratta, Domenico Ferro, Daniele Pastori, Alessandra Colantoni, Nicholas Cocomello, Mattia Coronati, Francesco Angelico, Maria Del Ben. Open Issues in the Transition from NAFLD to MAFLD: The Experience of the Plinio Study. International Journal of Environmental Research and Public Health 2021; 18(17): 8993 doi: 10.3390/ijerph18178993
|
8 |
Marek Hartleb, Agnieszka Mastalerz-Migas, Piotr Kowalski, Bogusław Okopień, Branko Popovic, Katarzyna Proga, Beata Cywińska-Durczak. Healthcare practitioners’ diagnostic and treatment practice patterns of nonalcoholic fatty liver disease in Poland: a cross-sectional survey. European Journal of Gastroenterology & Hepatology 2022; 34(4): 426 doi: 10.1097/MEG.0000000000002288
|
9 |
Ioanna Aggeletopoulou, Maria Kalafateli, Efthymios P. Tsounis, Christos Triantos. Epigenetic Regulation in Lean Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2023; 24(16): 12864 doi: 10.3390/ijms241612864
|
10 |
Hawal Lateef Fateh, Sameeah Abdulrahman Rashid, Sarmad S. Muhammad, Sabah H. Al-Jaf, Ayad M. Ali. Comparing effects of beetroot juice and Mediterranean diet on liver enzymes and sonographic appearance in patients with non-alcoholic fatty liver disease: a randomized control trials. Frontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1181706
|
11 |
Kushila Rupasinghe, Jonathan Hind, Robert Hegarty. Updates in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) in Children. Journal of Pediatric Gastroenterology & Nutrition 2023; 77(5): 583 doi: 10.1097/MPG.0000000000003919
|
12 |
Myung Jin Kim, Yun Kyung Cho, Eun Hee Kim, Min Jung Lee, Woo Je Lee, Hong‐Kyu Kim, Chang Hee Jung. Association between metabolic dysfunction‐associated steatotic liver disease and myosteatosis measured by computed tomography. Journal of Cachexia, Sarcopenia and Muscle 2024; 15(5): 1942 doi: 10.1002/jcsm.13543
|
13 |
Isabel Song, Elizabeth W. Thompson, Anurag Verma, Matthew T. MacLean, Jeffrey Duda, Ameena Elahi, Richard Tran, Pavan Raghupathy, Sophia Swago, Mohamad Hazim, Abhijit Bhattaru, Carolin Schneider, Marijana Vujkovic, Drew A. Torigian, Charles E. Kahn, James C. Gee, Arijitt Borthakur, Colleen M. Kripke, Christopher C. Carson, Rotonya Carr, Qasim Jehangir, Yi-An Ko, Harold Litt, Mark Rosen, David A. Mankoff, Mitchell D. Schnall, Haochang Shou, Julio Chirinos, Scott M. Damrauer, Marina Serper, Jinbo Chen, Daniel J. Rader, Marylyn D. Ritchie, JoEllen Weaver, Nawar Naseer, Afiya Poindexter, Khadijah Hu-Sain, Meghan Livingstone, Fred Vadivieso, Stephanie DerOhannessian, Teo Tran, Julia Stephanowski, Monica Zielinski, Ned Haubein, Joseph Dunn, Anurag Verma, Colleen M. Kripke, Marjorie Risman, Renae Judy, Shefali S. Verma, Yuki Bradford, Scott Dudek, Theodore Drivas, Walter R. T. Witschey, Hersh Sagreiya. Clinical correlates of CT imaging-derived phenotypes among lean and overweight patients with hepatic steatosis. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-023-49470-x
|
14 |
Nahum Méndez-Sánchez, Willem Pieter Brouwer, Frank Lammert, Yusuf Yilmaz. Metabolic dysfunction associated fatty liver disease in healthy weight individuals. Hepatology International 2024; 18(S2): 884 doi: 10.1007/s12072-024-10662-w
|
15 |
Agostino Di Ciaula, Federico Carbone, Harshitha Shanmugham, Emilio Molina-Molina, Leonilde Bonfrate, Stefano Ministrini, Fabrizio Montecucco, Piero Portincasa. Adiponectin involved in portal flow hepatic extraction of 13C-methacetin in obesity and non-alcoholic fatty liver. European Journal of Internal Medicine 2021; 89: 56 doi: 10.1016/j.ejim.2021.03.036
|
16 |
Seul Ki Han, Soon Koo Baik, Moon Young Kim. Non-alcoholic fatty liver disease: Definition and subtypes. Clinical and Molecular Hepatology 2023; 29(Suppl): S5 doi: 10.3350/cmh.2022.0424
|
17 |
Milena Vesković, Milka Pejović, Nikola Šutulović, Dragan Hrnčić, Aleksandra Rašić-Marković, Olivera Stanojlović, Dušan Mladenović. Exploring Fibrosis Pathophysiology in Lean and Obese Metabolic-Associated Fatty Liver Disease: An In-Depth Comparison. International Journal of Molecular Sciences 2024; 25(13): 7405 doi: 10.3390/ijms25137405
|
18 |
Basile Njei, Prince Ameyaw, Yazan Al-Ajlouni, Lea-Pearl Njei, Sarpong Boateng. Diagnosis and Management of Lean Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Systematic Review. Cureus 2024; doi: 10.7759/cureus.71451
|
19 |
Yu Jia, Yiheng Zhou, Yi Lei, Rui Zeng, Zhi Wan, Dongze Li, Qian Zhao, Xiaoyang Liao. Independent and joint relationships of cardiorespiratory fitness and body mass index with liver fat content. Diabetes, Obesity and Metabolism 2024; 26(11): 5087 doi: 10.1111/dom.15847
|
20 |
Hyun Kyung Kim, Do-Young Kim, Sumin Kang, Hayoon Kim, Jun-Mo Kim, Gwang-woong Go. Lean metabolic dysfunction-associated steatotic disease is reversed by betulinic acid, a therapeutic triterpene from birch bark. Food Bioscience 2024; 62: 104376 doi: 10.1016/j.fbio.2024.104376
|
21 |
Jiang Deng, Yonghong Zhang, Limei Bu, Haitao Shi, Hailing Tang, Shenhao Wang, Qian Wang, Shuangsuo Dang, Ming Li, Zhiyi Han, Xiaolan Lu. The Prevalence, Popular Trends, and Associated and Predictive Factors of Non-Obese Fatty Liver Disease. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.744710
|
22 |
Chukwunonso Ezeani, Chidiebele Omaliko, Yazan A Al-Ajlouni, Basile Njei. Mortality, Hepatic Decompensation, and Cardiovascular- and Renal-Related Outcomes in Lean Versus Non-lean Patients Hospitalized With Metabolic Dysfunction-Associated Steatohepatitis (MASH). Cureus 2024; doi: 10.7759/cureus.60968
|
23 |
Madhumita Premkumar, Anil C. Anand. Lean Fatty Liver Disease: Through Thick and Thin. Journal of Clinical and Experimental Hepatology 2021; 11(5): 523 doi: 10.1016/j.jceh.2021.06.011
|
24 |
Melissa Lopez-Pentecost, Martha Tamez, Josiemer Mattei, Elizabeth T. Jacobs, Cynthia A. Thomson, David O. Garcia. Adherence to a Traditional Mexican Diet Is Associated with Lower Hepatic Steatosis in US-Born Hispanics of Mexican Descent with Overweight or Obesity. Nutrients 2023; 15(23): 4997 doi: 10.3390/nu15234997
|
25 |
Tae Jung Oh, Kyuho Kim, Jae Hoon Moon, Sung Hee Choi, Nam H Cho, Hak Chul Jang. Liver Fibrosis Indices for the Prediction of Mortality in Korean Subjects: A 16-Year Prospective Cohort Study. Journal of the Endocrine Society 2021; 5(10) doi: 10.1210/jendso/bvab123
|
26 |
Ana Calin-Necula, Vlad Enciu, Priscila Ologeanu, Alexandru Constantin Moldoveanu, Carmen Fierbinteanu Braticevici. The correlation between Body Mass Index and histological features of Nonalcoholic Fatty Liver Disease. Romanian Journal of Internal Medicine 2023; 61(3): 147 doi: 10.2478/rjim-2023-0011
|
27 |
Hongyan Wang, Yuxue Zhang, Yupeng Liu, Hui Li, Ruiling Xu, Hongmei Fu, Chaoqi Yan, Bo Qu. Comparison between traditional and new obesity measurement index for screening metabolic associated fatty liver disease. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1163682
|
28 |
D. V. Sidorenko, V. D. Nazarov, S. V. Lapin, V. L. Emanuel, K. L. Raikhelson, V. P. Gomonova. Association of the p.I148m polymorphism in the <i>PNPLA3</i> gene with the severity of nonalcoholic fatty liver disease in various clinical groups. The Scientific Notes of the Pavlov University 2023; 30(4): 43 doi: 10.24884/1607-4181-2023-30-4-43-51
|
29 |
Soo Lim, Jin-Wook Kim, Giovanni Targher. Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease. Trends in Endocrinology & Metabolism 2021; 32(7): 500 doi: 10.1016/j.tem.2021.04.008
|
30 |
Anna Di Bartolomeo, Jacob George. Metabolic Steatotic Liver Disease. 2024; : 297 doi: 10.1016/B978-0-323-99649-5.00016-9
|
31 |
Shan Hong, Lei Sun, Yiwei Hao, Ping Li, Yuling Zhou, Xiuxia Liang, Julong Hu, Hongshan Wei. From NAFLD to MASLD: When metabolic comorbidity matters. Annals of Hepatology 2024; 29(2): 101281 doi: 10.1016/j.aohep.2023.101281
|
32 |
Yu-Ming Cheng, Shao-Wen Wang, Chia-Chi Wang, Jia-Horng Kao. Clinical characteristics of lean metabolic-associated fatty liver disease and the impact of concurrent diabetes mellitus. Tzu Chi Medical Journal 2024; 36(4): 425 doi: 10.4103/tcmj.tcmj_253_23
|